Study to Evaluate the Safety, Tolerability and PK of EC-18 After Oral Administration in Healthy Volunteers

NCT02532712 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-Induced Neutropenia

Interventions

DRUG: EC-18
DRUG: Placebo

Sponsor

Enzychem Lifesciences Corporation